Tevogen Bio Holdings Q1 EPS $(1.61) Beats $(2.50) Estimate

Benzinga Newsdesk www.benzinga.com Positive 69.5%

Neg 0% Neu 0% Pos 69.5%

Tevogen Bio Holdings (NASDAQ:TVGN) reported quarterly losses of $(1.61) per share which beat the analyst consensus estimate of $(2.50) by 35.6 percent. This is a 50.46 percent increase over losses of $(3.25) per share from the same period last year.